FBXO22 and hepatocellular carcinoma: Another F-box protein, FBXO22, is increased in hepatocellular carcinoma or cervical carcinoma, where it promotes cancer progression by binding to p57KIP2 and targeting it to degradation, similar to Fbxo22-mediated p21CIP degradation [160, 161].